Transplant for CLL: Still an option?

Abstract

In this issue of Blood, Dreger et al present a statement from the European Research Initiative on CLL (ERIC), providing a framework for discussing the role of allogeneic hematopoietic stem cell transplantation (HSCT) in the era of novel targeted agents for chronic lymphocytic leukemia (CLL).